Protara Therapeutics Company
Protara Therapeutics develops transformative therapies for people with cancer and rare diseases with limited treatment options.
Technology:
Cell therapy
Industry:
Private, Small&Large Molecules
Headquarters:
New York, New York, United States
Founded Date:
2017-01-01
Employees Number:
11-50
Funding Status:
M&A
Investors Number:
1
Total Funding:
4150000
Last Funding Date:
2022-05-20
Last Funding Type:
Seed
Register and Claim Ownership